Cargando…

Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung

BACKGROUND: Despite approvals of immune checkpoint inhibitors in both small cell and non-small cell lung cancers, the role of immunotherapy in large cell neuroendocrine carcinoma (LCNEC) in lung is undefined. METHODS: Using the National Cancer Database (NCDB), Stage IV lung LCNEC cases diagnosed fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komiya, Takefumi, Ravindra, Neema, Powell, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190341/ https://www.ncbi.nlm.nih.gov/pubmed/33639649 http://dx.doi.org/10.31557/APJCP.2021.22.2.365

Ejemplares similares

Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
por: Komiya, Takefumi, et al.
Publicado: (2023)

A Rare Presentation of Stage IV Large Cell Neuroendocrine Carcinoma of the Cervix with Metastasis to the Cranium
por: Hooker, Neema, et al.
Publicado: (2018)

Survival benefit from immunocheckpoint inhibitors in stage IV non‐small cell lung cancer patients with brain metastases: A National Cancer Database propensity‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer
por: Komiya, Takefumi, et al.
Publicado: (2020)

Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage
por: Lowczak, Anna, et al.
Publicado: (2021)

Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case Series
por: Dasari, Srikiran, et al.
Publicado: (2022)

Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2022)

Miliary Lung Metastases from Genital Large Cell Neuroendocrine Carcinomas
por: Sekine, Akimasa, et al.
Publicado: (2018)

Prognostic Impact of Single and Multiple Descriptors in Pathologically Staged T3N0M0 NSCLC
por: Komiya, Takefumi, et al.
Publicado: (2020)

Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis
por: Meng, Lingbin, et al.
Publicado: (2023)

Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer
por: Huang, Liling, et al.
Publicado: (2023)

Large-cell Neuroendocrine Carcinoma of the Lung with Carcinoid Syndrome
por: Yamamoto, Makoto, et al.
Publicado: (2022)

A Rare Case of Stage IV Mixed Neuroendocrine Small Cell and Adenosquamous Cell Carcinoma of the Gallbladder
por: Nuthulaganti, Swetha R, et al.
Publicado: (2022)

Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma
por: Li, Zefeng, et al.
Publicado: (2022)

Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung
por: Itoga, Masamichi, et al.
Publicado: (2021)

Treatment options for patients with large cell neuroendocrine carcinoma of the lung
por: Iyoda, Akira, et al.
Publicado: (2014)

Large Cell Neuroendocrine Carcinoma of the Lung with Cancer-Associated Retinopathy
por: Nakamura, Takahiko, et al.
Publicado: (2015)

Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
por: Andrini, Elisa, et al.
Publicado: (2022)

Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study
por: Wang, Jian, et al.
Publicado: (2019)

Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma
por: Zhou, Zhen, et al.
Publicado: (2019)

Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma
por: Liang, Zuoyu, et al.
Publicado: (2022)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung
por: Gu, Jianjun, et al.
Publicado: (2019)

Intracardiac Metastasis from a Large Cell Neuroendocrine Lung Carcinoma
por: Gaisendrees, Christopher, et al.
Publicado: (2019)

The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung
por: Buium, Catalin, et al.
Publicado: (2023)

Management of Large Cell Neuroendocrine Carcinoma
por: Corbett, Virginia, et al.
Publicado: (2021)

Large-cell neuroendocrine carcinoma of the cervix
por: Yoseph, Benyam, et al.
Publicado: (2012)

Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022)

Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma
por: Andreetti, Claudio, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
por: Wegner, Rodney E, et al.
Publicado: (2020)

Double trouble: combined large-cell neuroendocrine and small-cell lung carcinoma
por: Fisch, David, et al.
Publicado: (2022)

Combined large cell neuroendocrine carcinoma with giant cell carcinoma of the lungs: a case report
por: Hayashi, Satoshi, et al.
Publicado: (2013)

Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC)
por: Recuero, Enrique, et al.
Publicado: (2023)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023)

Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States
por: May, Michael S., et al.
Publicado: (2021)

Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung
por: Moon, Jin Young, et al.
Publicado: (2021)

Large cell neuroendocrine carcinoma of the lung presenting as pseudoachalasia: a case report
por: Anaizi, Ahmad, et al.
Publicado: (2015)

Cancer-associated Retinopathy with Neuroendocrine Combined Large-cell Lung Carcinoma and Adenocarcinoma
por: Yagyu, Kyoko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_manp9f4k5in70ej7fssli35883